title: Metabolic Syndrome and Menopause: Pathophysiology, Clinical and Diagnostic Significance.
abstract: Menopause is a risk factor for cardiometabolic diseases, including metabolic syndrome (MetS), type 2 diabetes, and cardiovascular diseases. MetS is a constellation of interdependent factors such as insulin resistance, abdominal obesity, dyslipidemia, and hypertension. The prevalence of MetS in postmenopause is due to loss of the protective role of estrogens and increased circulating androgens resulting in changes to body fat distribution and development of abdominal obesity. Excessive visceral adipose tissue plays an important role due to synthesis and secretion of bioactive substances such as adipocytokines, proinflammatory cytokines, reactive oxygen species, prothrombotic, and vasoconstrictor factors. MetS may also impact risk assessment of breast cancer, osteoporosis and chronic kidney disease, and quality of life during the menopausal transition. Increased MetS has stimulated the exploration of new laboratory tests for early detection and therapies.
authors.affiliation: Department of Laboratory Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland. Electronic address: diag.ka@wp.pl.
authors.forename: Anna
authors.initials: A
authors.lastname: Stefanska
authors.affiliation: Department of Laboratory Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Bergmann
authors.affiliation: Department of Laboratory Medicine, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland.
authors.forename: Grazyna
authors.initials: G
authors.lastname: Sypniewska
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D008593:Menopause; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000503:physiopathology*; D008875:Middle Aged
keywords: Cardiovascular disease; Insulin resistance; Menopause; Metabolic syndrome; Sex hormones